-
Darlene Dixon
National Institute of Environmental Health Sciences, National Toxicology Program, Research Triangle Park, North Carolina, USA
-
Roger Alison
Roger Alison Ltd, Pathology Consultancy Services, Caerfyrddin Fach, Cilcennin, Lampeter, SA48 8RN, United Kingdom
-
Ute Bach
Bayer Pharma AG, Wuppertal, Germany
-
Karyn Colman
Novartis Institute for Biomedical Research, Novartis, East Hanover, New Jersey, USA
-
George L. Foley
AbbVie, Inc., North Chicago, Illinois, USA
-
Johannes H. Harleman
Fresenius Kabi Deutschland GmbH, Bad Homburg, Germany
-
Richard Haworth
GlaxoSmithKline R&D, Park Road, Ware, Hertfordshire, SG12 ODP, United Kingdom
-
Ronald Herbert
National Institute of Environmental Health Sciences, National Toxicology Program, Research Triangle Park, North Carolina, USA
-
Anke Heuser
Roche Pharma Research and Early Development, Roche Innovation Center Basel, Grenzacher Strasse 124, 4070 Basel, Switzerland
-
Gerald Long
Experimental Pathology Laboratories, Indianapolis, Indiana, USA
-
Michael Mirsky
Pfizer Worldwide Research and Development, Groton, Connecticut, USA
-
Karen Regan
Regan Path/Tox Services, Ashland, Ohio, USA
-
Eric Van esch
InSight Pathology BV, Chopinlaan 6, Oss, The Netherlands
-
F. Russell Westwood
AstraZeneca, Macclesfield, Cheshire, United Kingdom (Retired)
-
Justin Vidal
National Institute of Environmental Health Sciences, National Toxicology Program, Research Triangle Park, North Carolina, USA
-
Midori Yoshida
National Institute of Health Sciences, Tokyo, Japan
-
Author's Organization:GlaxoSmithKline, King of Prussia, Pennsylvania, USA